Two Neuraminidase Inhibitors for Treatment of Influenza
Zanamivir, a neuraminidase inhibitor taken by inhalation, has been approved by the FDA for treatment of influenza. Oseltamivir phosphate, an oral neuraminidase inhibitor, will probably be approved soon....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Two Neuraminidase Inhibitors for Treatment of Influenza
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1063
Article Code: 1063a
Date: October 8, 1999
Volume: 41
Pages: 91-93
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1063
Article Code: 1063a
Date: October 8, 1999
Volume: 41
Pages: 91-93
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)